| BACHEM HLDG NA SF 0,01 |
| Schweiz |
| Gesundheit |
| CH1176493729 / A3DLKE |
| BHM0 (Frankfurt) |
| FRA:BHM0, ETR:BHM0, BHM0:GR |
| - |
| https://www.bachem.com/ |
|
Bachem Holding AG is a Swiss biotechnology company specializing in the development and manufacturing of peptides and oligonucleotides for research, clinical development, and commercial applications. F..
>Volltext.. |
| 5043.5 Mio. EUR |
| 5072.09 Mio. EUR |
| 767.96 Mio. EUR |
| 209.79 Mio. EUR |
| 164.4 Mio. EUR |
| 2.19 EUR |
| 63.41 Mio. EUR |
| 34.24 Mio. EUR |
| 299.82 Mio. EUR |
| 0.08 |
| 15.96% |
| 24.94% |
| - |
| 1.41% |
| 1.49% |
| 21.04.23 - 0.810825€ 29.04.22 - 0.151353992€ >weitere anzeigen... |
| - |
| BACHEM |
| 14.03.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|